Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
What if your blood could predict your response to cancer treatment?
Dr. Suzanne Kamel-Reid, Head, Laboratory Genetics, UHN, has been exploring how that question applies to lung cancer patients since 2016.
The results of her study, co-led by Dr. Ming-Sound Tsao, Senior Scientist, and Dr. Tracy Stockley, Associate Director, Laboratory Genetics with the Princess Margaret, used blood to predict the presence of a mutation in tissue to optimize treatment.
"We've been able to optimize and validate a simple blood test, and now implement it clinically," says Dr. Kamel-Reid. "We believe we are the first lab in Canada to offer this to our patients."
Samples were studied at laboratories across the country, including Ontario, British Columbia, Alberta, Quebec, and Nova Scotia.
"Tumours shed cells and those cells release DNA, and we are looking for that DNA," says Dr. Kamel-Reid. "It's at very low levels, so you have to have technology that can detect it very sensitively."
As of October 2017, this liquid biopsy test is being offered to patients across Ontario. Dr. Kamel-Reid says the same non-invasive methodology could also be used to test for mutations in other cancers.
The “Transformers” magazine by The Princess Margaret Cancer Foundation focuses on how the Princess Margaret Cancer Centre is adopting new methods, including the power of machine learning and artificial intelligence, to deliver precision medicine and transform cancer care.